28 November 2017 - Deborah Wilkes
Bayer Consumer Health is striving to return its US business to growth following a decline in North American sales during the first nine months of 2017.
Read all about Bayer Consumer Health's plans to return its US business to growth in this NEWS EXTRA publication from OTCToolbox.
Germany's Bayer transformed its consumer healthcare operations in October 2014 when it acquired US-based Merck & Co's Consumer Care business for USD14.2 billion.
Three years later, however, Bayer Consumer Health is struggling in the US.
Bayer has just recruited a new worldwide head of the Consumer Health business to replace Erica Mann, who is leaving with effect from 31 March 2018. Heiko Schipper is joining from food and drink company Nestlé.
Download the publication today to find out more about Bayer Consumer Health's:
– Plans in the US
– Recent financial results
– Approach to acquisitions
– Views on e-commerce
– Partnership with Alibaba Health
– Line extensions
– New worldwide head
The News Extra is available to purchase and download immediately from the OTCToolbox website. You can make sure your team is well informed through a Multiple User Licence or a Global Licence.
This essential reading is available free to people with an Annual Subscription to the OTCToolbox website (click here to find out more).
RAPID INSIGHTS MADE EASY
AVAILABLE TO DOWNLOAD IMMEDIATELY AS A PDF
See Payment Options box at the top of this page
For alternative payment options and delivery methods, or other questions, please send an email to firstname.lastname@example.org.